These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30154079)

  • 1. Zoledronic acid prevents pagetic-like lesions and accelerated bone loss in the p62
    Daroszewska A; Rose L; Sarsam N; Charlesworth G; Prior A; Rose K; Ralston SH; van 't Hof RJ
    Dis Model Mech; 2018 Aug; 11(9):. PubMed ID: 30154079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A SQSTM1/p62 mutation linked to Paget's disease increases the osteoclastogenic potential of the bone microenvironment.
    Hiruma Y; Kurihara N; Subler MA; Zhou H; Boykin CS; Zhang H; Ishizuka S; Dempster DW; Roodman GD; Windle JJ
    Hum Mol Genet; 2008 Dec; 17(23):3708-19. PubMed ID: 18765443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget's disease-like disorder in mice.
    Daroszewska A; van 't Hof RJ; Rojas JA; Layfield R; Landao-Basonga E; Rose L; Rose K; Ralston SH
    Hum Mol Genet; 2011 Jul; 20(14):2734-44. PubMed ID: 21515589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contributions of the measles virus nucleocapsid gene and the SQSTM1/p62(P392L) mutation to Paget's disease.
    Kurihara N; Hiruma Y; Yamana K; Michou L; Rousseau C; Morissette J; Galson DL; Teramachi J; Zhou H; Dempster DW; Windle JJ; Brown JP; Roodman GD
    Cell Metab; 2011 Jan; 13(1):23-34. PubMed ID: 21195346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased IL-6 expression in osteoclasts is necessary but not sufficient for the development of Paget's disease of bone.
    Teramachi J; Zhou H; Subler MA; Kitagawa Y; Galson DL; Dempster DW; Windle JJ; Kurihara N; Roodman GD
    J Bone Miner Res; 2014 Jun; 29(6):1456-65. PubMed ID: 24339057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p62/sequestosome 1 deficiency accelerates osteoclastogenesis
    Zach F; Polzer F; Mueller A; Gessner A
    J Biol Chem; 2018 Jun; 293(24):9530-9541. PubMed ID: 29555685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zoledronate in the prevention of Paget's (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent
    Cronin O; Forsyth L; Goodman K; Lewis SC; Keerie C; Walker A; Porteous M; Cetnarskyj R; Ranganath LR; Selby PL; Hampson G; Chandra R; Ho S; Tobias JH; Young-Min S; McKenna MJ; Crowley RK; Fraser WD; Gennari L; Nuti R; Brandi ML; Del Pino-Montes J; Devogelaer JP; Durnez A; Isaia G; Di Stefano M; Guañabens N; Blanch J; Seibel MJ; Walsh JP; Kotowicz MA; Nicholson GC; Duncan EL; Major G; Horne A; Gilchrist NL; Boers M; Murray GD; Charnock K; Wilkinson D; Russell RGG; Ralston SH
    BMJ Open; 2019 Sep; 9(9):e030689. PubMed ID: 31488492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mutation (K378X) in the sequestosome 1 gene associated with increased NF-kappaB signaling and Paget's disease of bone with a severe phenotype.
    Rea SL; Walsh JP; Ward L; Yip K; Ward BK; Kent GN; Steer JH; Xu J; Ratajczak T
    J Bone Miner Res; 2006 Jul; 21(7):1136-45. PubMed ID: 16813535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The p62 P392L mutation linked to Paget's disease induces activation of human osteoclasts.
    Chamoux E; Couture J; Bisson M; Morissette J; Brown JP; Roux S
    Mol Endocrinol; 2009 Oct; 23(10):1668-80. PubMed ID: 19589897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profile in osteoclasts from patients with Paget's disease of bone.
    Michou L; Chamoux E; Couture J; Morissette J; Brown JP; Roux S
    Bone; 2010 Mar; 46(3):598-603. PubMed ID: 19925894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p62 ubiquitin binding-associated domain mediated the receptor activator of nuclear factor-kappaB ligand-induced osteoclast formation: a new insight into the pathogenesis of Paget's disease of bone.
    Yip KH; Feng H; Pavlos NJ; Zheng MH; Xu J
    Am J Pathol; 2006 Aug; 169(2):503-14. PubMed ID: 16877352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etiologic factors in Paget's disease of bone.
    Reddy SV
    Cell Mol Life Sci; 2006 Feb; 63(4):391-8. PubMed ID: 16429324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quest for clarity in bone erosion: The role of sequestosome 1 in Paget's disease of bone.
    Michalski MN; Williams BO
    J Biol Chem; 2018 Jun; 293(24):9542-9543. PubMed ID: 29907733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Implications of the Sequestosome 1 Mutation P392L in Patients with Paget's Disease in a United States Cohort.
    Seton M; Hansen M; Solomon DH
    Calcif Tissue Int; 2016 May; 98(5):489-96. PubMed ID: 26713335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised trial of genetic testing and targeted intervention to prevent the development and progression of Paget's disease of bone.
    Phillips J; Subedi D; Lewis SC; Keerie C; Cronin O; Porteous M; Moore D; Cetnarskyj R; Ranganath L; Selby PL; Turgut T; Hampson G; Chandra R; Ho S; Tobias J; Young-Min S; McKenna MJ; Crowley RK; Fraser WD; Tang JCY; Gennari L; Nuti R; Brandi ML; Del Pino-Montes J; Devogelaer JP; Durnez A; Isaia GC; Di Stefano M; Guanabens N; Blanch Rubio J; Seibel MJ; Walsh JP; Rea SL; Kotowicz MA; Nicholson GC; Duncan EL; Major G; Horne A; Gilchrist N; Ralston SH
    Ann Rheum Dis; 2024 Mar; 83(4):529-536. PubMed ID: 38123339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of bone.
    Menaa C; Reddy SV; Kurihara N; Maeda H; Anderson D; Cundy T; Cornish J; Singer FR; Bruder JM; Roodman GD
    J Clin Invest; 2000 Jun; 105(12):1833-8. PubMed ID: 10862799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease.
    Kurihara N; Hiruma Y; Zhou H; Subler MA; Dempster DW; Singer FR; Reddy SV; Gruber HE; Windle JJ; Roodman GD
    J Clin Invest; 2007 Jan; 117(1):133-42. PubMed ID: 17187080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A FKBP5 mutation is associated with Paget's disease of bone and enhances osteoclastogenesis.
    Lu B; Jiao Y; Wang Y; Dong J; Wei M; Cui B; Sun Y; Wang L; Zhang B; Chen Z; Zhao Y
    Exp Mol Med; 2017 May; 49(5):e336. PubMed ID: 28524179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D(3) and RANKL.
    Neale SD; Smith R; Wass JA; Athanasou NA
    Bone; 2000 Sep; 27(3):409-16. PubMed ID: 10962353
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.